| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |